Awards & Advancement

Fosun Kite Biotechnology names Richard L. Wang chief executive officer

Monday, March 6, 2017

Kite Pharma announced that Richard L. Wang, Ph.D. will be appointed chief executive officer of Fosun Kite Biotechnology Co., Ltd, the company’s 50/50 owned joint venture in China with Shanghai Fosun Pharmaceutical (Group) Co., Ltd.The companies announced the formation of the joint venture in early 2017 to develop, manufacture and commercialize autologous T-cell therapies to treat cancer in China, including Kite’s lead cell therapy product candidate, axicabtagene ciloleucel. Final registration of the joint venture is ongoing.

[Read More]

Patrick Soon-Shiong awarded Special Recognition Award

Monday, March 6, 2017

Patrick Soon-Shiong, M.D., CEO and founder of NantHealth, has been awarded the Intelligent Health Association (IHA) Special Recognition Award. The award recognizes his leadership in the healthcare technology community and his commitment to transforming cancer care through personalized medicine and combination immunotherapy.

[Read More]

Cambridge Epigenetix Establishes Scientific Advisory Board

Monday, March 6, 2017

Cambridge Epigenetix, a developer of epigenetic technologies, has announced the formation of its Scientific Advisory Board (SAB). The SAB comprises experts for Cambridge Epigenetix’s key focus areas, including oncology, liquid biopsy and ageing. They form a key strategic resource and provide their unique research perspectives as the company transitions towards becoming an integrated commercial epigenetic biomarker discovery venture.

[Read More]

ERT appoints Ellen Street to executive management team

Monday, March 6, 2017

ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials, has announced the appointment of Ellen Street as executive vice president, Cardiac Safety. Street has more than 20 years of product management, commercial leadership and strategic marketing experience across multiple segments of the life sciences industry, including her most recent role as VP and general manager, Global Monitoring Solutions Ecosystem & Analytics at GE Healthcare.

[Read More]

PAREXEL International appoints Simon Harford as SVP & CFO

Tuesday, February 28, 2017

PAREXEL International, a global biopharmaceutical services provider, has announced the appointment of Simon Harford as senior vice president and chief financial officer effective June 1, 2017. He will serve on PAREXEL’s Business Review Committee, the company’s senior-most leadership team, and assist in developing and implementing PAREXEL’s strategic objectives. Harford will be based at the Company’s corporate headquarters in Waltham, Massachusetts.

[Read More]

Scott Smith promoted to Celgene president and chief operating officer

Tuesday, February 28, 2017

Celgene has announced that president and chief operating officer (COO) Jacqualyn (Jackie) Fouse, Ph.D., has decided to retire from Celgene effective June 30, 2017. She will continue to serve as president and COO until April 1, and through June 30, she will serve as a strategic advisor to the management team. Jackie will not stand for reelection to the Celgene Board of Directors at the upcoming Annual Meeting in June. The company also announced the promotion of Scott Smith to President and COO, effective April 1, 2017, and the promotion of Terrie Curran to president, Global Inflammation & Immunology (I&I) Franchise, effective April 1, 2017.

[Read More]

SanBio’s stroke stem cell treatment receives innovation award from American Heart Association

Tuesday, February 28, 2017

SanBio, a provider of regenerative medicine for neurological disorders, announced that a recent publication of its novel stem cell treatment, SB623, for patients following a stroke, has received a prestigious award from the American Heart Association. The scientific article, “Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase I/IIa Study,” was the third prize winner of the 2016 Stroke Progress and Innovation Award.

[Read More]

PureTech Health appoints Atul Pande chief medical officer

Friday, February 24, 2017

PureTech Health, a cross-disciplinary biopharmaceutical company, has announced the appointment of Atul Pande, M.D., as the company’s chief medical officer. In this new role, Dr. Pande will oversee all clinical operations across PureTech Health’s pipeline and work closely with the team to de-risk and advance opportunities that hold the most potential for patients.

[Read More]